Menu
Back to User profile » Dr Edward M Kerwin
Papers published by Dr Edward M Kerwin:
A Dose-Ranging Study of the Novel Inhaled Dual PDE 3 and 4 Inhibitor Ensifentrine in Patients with COPD Receiving Maintenance Tiotropium Therapy
Ferguson GT, Kerwin EM, Rheault T, Bengtsson T, Rickard K
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:1137-1148
Published Date: 22 April 2021
Onset of Effect, Changes in Airflow Obstruction and Lung Volume, and Health-Related Quality of Life Improvements with Benralizumab for Patients with Severe Eosinophilic Asthma: Phase IIIb Randomized, Controlled Trial (SOLANA) [Corrigendum]
Panettieri RA Jr, Welte T, Shenoy KV, Korn S, Jandl M, Kerwin EM, Feijoo R, Barker P, Olsson RF, Martin UJ
Journal of Asthma and Allergy 2020, 13:135-136
Published Date: 13 March 2020
Onset of Effect, Changes in Airflow Obstruction and Lung Volume, and Health-Related Quality of Life Improvements with Benralizumab for Patients with Severe Eosinophilic Asthma: Phase IIIb Randomized, Controlled Trial (SOLANA)
Panettieri RA Jr, Welte T, Shenoy KV, Korn S, Jandl M, Kerwin EM, Feijoo R, Barker P, Olsson RF, Martin UJ
Journal of Asthma and Allergy 2020, 13:115-126
Published Date: 17 February 2020
AMPLIFY: a randomized, Phase III study evaluating the efficacy and safety of aclidinium/formoterol vs monocomponents and tiotropium in patients with moderate-to-very severe symptomatic COPD
Sethi S, Kerwin E, Watz H, Ferguson GT, Mroz RM, Segarra R, Molins E, Jarreta D, Garcia Gil E
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:667-682
Published Date: 22 March 2019
Effect of background long-acting beta2-agonist therapy on the efficacy and safety of a novel, nebulized glycopyrrolate in subjects with moderate-to-very-severe COPD
Kerwin EM, Tosiello R, Price B, Sanjar S, Goodin T
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:2917-2929
Published Date: 19 September 2018
Efficacy, safety, and pharmacokinetics of budesonide/formoterol fumarate delivered via metered dose inhaler using innovative co-suspension delivery technology in patients with moderate-to-severe COPD
Kerwin EM, Siler TM, Arora S, Darken P, St Rose E, Reisner C
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:1483-1494
Published Date: 8 May 2018